Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

This study reviews the regenerative potential and clinical applications of exosomes derived from mesenchymal stem cells in conditions like COVID-19, alopecia, skin aging, and osteoarthritis, highlighting their role as a promising tool in regenerative medicine.

This article outlines how pediatric hair problems present and how they can be assessed, without reporting new research results.

This review suggests that platelet-rich plasma may be effective in increasing hair density in patients with androgenetic alopecia, but more research is needed to determine the best treatment protocol.

This study found that hair follicle stem cells could enhance burn wound healing and improve tissue tensile strength in rats.

This review discusses the histologic features of nonscarring alopecia and highlights the importance of clinical-pathological correlation for accurate diagnosis, but reports no new clinical results.

This study found that canine hair follicle stem cells are located in the isthmus/bulge region of the hair follicle, surrounded by telocytes.

This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.

This study, examining perceptible hair density changes in androgenetic alopecia patients, found that dermatologists could accurately detect hair loss at a lower threshold than previously noted, specifically at a 22.66% relative density difference, challenging assumptions about their predictive accuracy based solely on clinical examination.

This article discusses aspects of evaluating patients with androgenetic alopecia for hair transplantation and reports no clinical results.

This study found no significant benefit from PRP injections for treating androgenetic alopecia in men, highlighting the need for larger, well-designed trials to assess its effectiveness and safety.

This review discusses the various determinants of hair quality in healthy individuals and reports no new clinical results; the authors emphasize the need for independent trials with standardized outcomes.

In this study, creatine supplementation over 12 weeks showed no effect on androgen levels or hair follicle health in healthy young males, challenging the belief that creatine causes hair loss.

This study found that increased atypical club hair observed in microscopic hair examinations may be characteristic of telogen effluvium compared to healthy individuals and diffuse alopecia areata patients.

This study found that platelet-rich plasma therapy may effectively treat androgenetic alopecia and could potentially replace topical minoxidil, offering promising results in terms of hair growth and patient satisfaction.

In this study reviewing recent literature, researchers found limited high-quality evidence supporting the use of adipose-derived stem cells for androgenic alopecia and alopecia areata, suggesting a need for further randomized controlled trials to better assess their efficacy.

Zinc deficiency causes early scalp hair damage that recovers slower than skin symptoms.

In this study, trichoscopic examination revealed that patients with androgenetic alopecia had significantly more yellow dots, pilosebaceous units with one hair, and increased perifollicular hyperpigmentation compared to healthy controls.

This article reviews optimal patient selection and donor site quality for successful hair transplant procedures, but reports no new clinical findings.

This study examined hair follicles from 14 Caucasian males and found that catagen-phase follicles were more prevalent (7.5%) than previously reported, challenging the established view that telogen-phase follicles are more common.

This study found that a marine-extract dietary supplement significantly reduced hair shedding and increased hair diameter in premenopausal women with subclinical hair thinning or hair loss after 6 months of use.

This study found that a keratin mutation may cause diffuse partial woolly hair associated with loose anagen hair syndrome in some families, but other genetic factors could play a role in different cases.

This study reports that Edelweiss extract significantly prolonged the anagen phase and increased hair density, suggesting potential as an anti-hair loss treatment.

In this study, no significant association was found between the severity of androgenetic alopecia in males and trichoscopy features such as hair diameter diversity, vellus hair, and white dots, suggesting that trichoscopy may not predict alopecia severity based on the Hamilton–Norwood scale.

In this study, PRP therapy did not show significant effectiveness in treating androgenetic alopecia in patients over a 6-month period, with 45% of participants reporting no improvement in hair growth, although adverse effects were minimal and non-serious.

In this study, researchers found that trichoscopy helps detect early signs of female-pattern hair loss before it is visible, highlighting its importance for monitoring and managing the condition.

This study found that certain C57BL/6 mouse substrains have a genetic vulnerability to skin lesions resembling central centrifugal cicatrical alopecia in humans, potentially worsened by high vitamin A levels.

This study found that a refined wash test can effectively differentiate shedding hair characteristics among normal individuals, and patients with androgenetic alopecia or telogen effluvium, aiding in diagnosis and monitoring.